Create a proposed plan on how Merck & Co. can regain the publics trust and rebuild the firms reputation within the pharmaceutical industry.

What is Viess" Discovedina Mexkreach facility in 1994 Vi n os p ically among a class of drugs called Cox-2 inhibitors. This class of p ilgrus www reduce pain and information in the human body Corinhibits compete with the drugs known as serial anti- drugs (NSAIDs) that reduce prin Alhegh Co w heart of the NSAIDs they were developed to reduce pain while climinating the effects of the NSAID and e stinal Mending Vit was approved by the Sun Admission (FDA) for the treatment of pain inflammation, and w e can There was a pproved for use in the treatment of them walls. Vixxis the only Cow inhibitor which is proven to be before Meeding Ar the w o rks by the Dead Sepw4 0 Khad to decide what to do wering results showing Viscond e pull the drug from the market Monday, September 27. for the decise for the three days an d Me the future de the at the come Men Os Sephor 2004Raymond Gimtin, Merck & C C F,made cement that would change thee of Merck the pharmac y Gilmarioned that Makwangit w i ll worldwide market. Al the time of the real out two million pouple week there's a wal in 1998, more than 100 million prescriptions and then wi t h The decision to pull View from the worldwide market was en daarom ritha Merchandised to whether Vierhadative price per potentially cances growth in the man with a wythem Data Mosing and find Mack officials that the y revealed that people whether than what the heat attackstroke than if they took a plache. According to De Kim."Being there was a disce and expected in an increascarica The poliminary results of Merck's study, along with the presence of the other in Plus Caland were the chance w e deciso pull Vis from the market Galima defended Mende th w ing the drug was to be there thing to do Warning Mund the wa y the The Medical sche The findings of the footh Mechincha The fact that the FDA required a label change due to the cheming showing the risks of Vi n d Other studies show that higher desapes of Vioxx can increase a prent's risk of Cardiovasculares even further in August 2004, Kaiser Permanente a large num b eath maintance organication, reviewed its patieconds of 14 million people who were taking one of the many sodal anti-inflammatory drugs, including 26.748 patients who were taking Vio Kaiser found that partic k ing Vier in dieses greater than 25 milligrams faced threefold increased risk of cardiovascular problem. Merck w ed this way, yingi w a surveyed on p r ecords rather than a clinical trial in the drag's effectiveness and side effects a c o oking a place E-mail within the company further Men who the danger. Vi even before the FDA approved the drug In F ury 1997. M a Merck official with p ing Viswold me thromboticesheed c h ey in weil Anther Mench e A Rekipedia way that Mack was in a w h i te ince can with all of the m pople when we were of the market Merck Study Backfires d'home with h is APPROVA polypepting the p erficio Mach Merck's they found th e heart aking the medicine for 18 m .compared to the participants taking a place This changepast h allasit is only a case in the work of candic Hetheri t ong Vies.which means Vi doubles aper 's chance to a tak The FDA Approval Process The United States Food and Drug Administration acknowledges that megis completely free The FDA approva drugely to undergoes through laboratory, animal and humans testing. The main port of the approval pre is the most extensive and instant The while in Exhibiti w a the different phases of human testing the wees clinical trials of pr a y paint the DA ginally approved Viis May 1999 The any claims that is c alley database on Vind ow an increased heart tack or from consuming the drug. However, the FDA desmit Vierend a six-month priority review became the re a lly provided a significant therapeutic Gri p ped to fewer side effects including Med E s ofman Testing Le Purpose Puties Sell Tested und C ase the lack of l e ave hearded the FDA does the quick al process of Vi n d other drups. The pharmaceutical industry, coding o ver and routiny press the FDA for approval of new drugs, despite clinical trials that way toe few patients for too short of time for side effects to emerge More than half of all drugs introduced have a w ide effect app with the current system." Fuera public health Science Wake Forest University Schoof Medicine Crystal Rio, an PDA spokeswoman responded. Our job is to pray balance ou decision e d on the benefit profile for drug and the social need and desire for new drugs Richard w o The Lawwali medical Journal, claims the FDA table for failing to a fra dem Verdanger M orten has da ver o of the cy's process for reviewing drug afty Sila at the FDA Partups the FDA or at least officials within the agency, did try to the ring of the cardiovascular dangers of Vies". Dr. David Graham, a c tor in the FDA Drug Center's Office of Drug Safety, said he faced fi opposite within the cyto findings that high dens of tripled o fheart with me of the Finance Com e on Thursday, Oct .2004 made after Finance Cover ed the wh o le R.lewa wady Graham describe ancient where he was t e veiled h and Senator Grassley added. Men d e hands and action the time, instead of acting as he wa s the Drug Admin was buy challenging export and calling We of Ar (NSAIDA DA CDL MGA dy All NSAID risks when chemically ding way. They should be w i der the prop p ing medicines in the we a the Day de Peland Berit will - they do the wheel Best The Sumed by hwy advertising COX off wh ether Apsar Celebrand View sale in 1999 Crities way that these indy hem de mollis est Vi row is strict of medical w ring they wo to be d uly af Merck pulled Viso the market, the FDA ordered P opullore Viagra athu did not disclose any of its ko ks Federalne w ytress before Merck's www Asia, which is cred to V w whefur sale by on in the The FDA d e Men's Aronia de tothe Vienrecall e ddial data Merk Pro Gebed Views For w e are 19 Mekad been dem American why are w e will View. mypeththathis reputatie would be show e r rady oblems before the format of the Med hace and was to be the c hemical indy Now that putte is being used and the calls they Se Merck were developing news by SISON with the company's shares losing just over half the value between 2001 2003 Men's camins have been in decline since 2001 and the company womeow final years eve 2003. Even though we wty Merck e n d decline in income for the wed with a decrease of Merdine the world's largest pharmaceutical company is w h ere the list. Merck Faces Criminal Probe and Laws In a quarterly regulatory filing on November 2004, Merck dicked USD Justice subpoenad the company as part of a criminal Merck's handling of Vir The company acknowledged that the Rustice Depo r ted from Merck reading the company's each marketing d e u tora federal healthcare investigador e s The c h est centered on whether or not Merck misled rou n d federal health for Vion when it was ward The m ed that the US Securities and Exchange Commission was launching an infi g M endoci Vi The inquiry is expected to investigate whether Meck l e d the row of clinical trials and other progesch e hehe add to the US Go v t Medbe that they facec Vinc e he pued by a report the FDA acces that we 27 000 the we of the drug. They is a defendamine 35 pou c o which were filled there's calling th e pisyeshe decide d the US Vio ligesonder specifices for the c a suwyer Da E Bendr who has led such a s in the past.Wecepce with pharmaceutical companies by one when we wechmem e At the end of 2004, the wave of lawsuits was expected to increas e the y believed that some of them might go to tralascary as 2005 Are Others at Full Although Merck heavily marketed Vioxx and the FDA never called the res despite may studies demonstrating is dangers, many people her e Some have Named dectors, ce companies, and the American health care the brotheart attacks caused by Vion Only a small p ic who 159 were benefiting from its lower incidence of stomach bleeding which is the main hocfit of the drug as opposed to the use of common, over-the-counter apron Man pa y with their doctors for not informing them that Alver Advil would work just a s if they were not susceptible to stomach bleeding free porn If so few people benefit from taking Vioxx S100 million a year in direct-to-consumer advertising for the problem to a regulatory system that drives the cost of develop which encourages are pharmaceutical farms to heavily bo why the many spend Somers e the e d to levels medic i ne baby e dicine. Even do c h ein w Docte poch e seem like What's Nest for Merck & Company For Joan Wawright overy day is a new day This mothered as the man officials Marck Co., Inc. ther e to deal with the call or View mes e s Ever since the recall September 2004 Merck has been the center of attention in the pharmaceutical industry. The y a r e market share Wall Street, in addition to declining sales and profit levels in the year 2000 Merck is facing a hamra of lawsuits and is the subject of two separate government s with all these issues on the doorstep. Joan Wainwright, weg with her must determine how Merck & Company with once again as the gold standard in the pas